At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Washington, United States based CFO’ operating in the Biotechnology space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Leonard Bruce Jolliff
Chief Financial Officer of Vivos Inc
Leonard Bruce Jolliff, joined Advanced Medical Isotope Corporation as Chief Financial Officer in 2006. For nine years prior to joining the Company, Mr. Jolliff was a sole practitioner in the role of CFO for Hire and as a Forensic Accountant, working with companies ranging from Fortune 500 to small family operations. Mr. Jolliff is a CPA and a member of the Washington Society of CPAs. He is also a Certified Fraud Examiner and a member of the Association of Certified Fraud Examiners. Mr. Jolliff has held CFO and Controller positions in an array of industries and has worked as a CPA in public practice. Currently all of Mr. Jolliff’s energy is focused on supporting AMI’s isotope production and securing new investments which will enable the growing company to meet it’s goals.
Follow Leonard Bruce Jolliff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Michael Banks
CFO of Kineta
Michael Banks serves as the Chief Financial Officer of Kineta.
Follow Michael Banks:
About Kineta: Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.
Jeremy Hux
CFO of Manus Bio
Jeremy Hux currently works as Chief Financial Officer at Manus Bio.
Follow Jeremy Hux:
About Manus Bio, Marathon Capital: Manus Bio makes nature accessible and affordable for a growing society.
Carol R. Jones
CFO of Etubics
Ms. Jones was previously Vice President and Managing Partner of Haidas Ranches, LLC land development from 1996 to 2003. Ms. Jones has more than 20 years of administrative experience in various environments including seven years at the University of Washington working as a Budget Coordinator overseeing 16 grants and contracts with six figure annual budgets. She also has management experience from McDonnell Douglas Aircraft and Pacific Telephone and Telegraph in addition to having been involved in the administrative functions of two other startup companies including IMRÉ Corporation, of which was brought public. She graduated from Steven Henager College, Salt Lake City, Utah.
Follow Carol R. Jones:
About Etubics: Biopharmaceutical company. developing targeted immunotherapies and vaccine products for a wide range of resilient diseases.
Mike Schuh
CFO of Cardiac Insight
With almost 30 years of experience in accounting and finance., Schuh was most recently (from 2000 until 2010) Vice President, Finance and Chief Financial Officer of SonoSite Inc., the pioneer and leader of point-of-care hand-carried ultrasound. During his tenure, worldwide sales grew from $10 million to $275 million and employees from 100 to 900.
Follow Mike Schuh:
About Cardiac Insight: Cardiac Insight is a privately-held medical device company that offers body-worn ECG sensing technology.
Shawn Gahr
Co-Founder, COO & CFO of Novoron Bioscience
Shawn Gahr is a co-founder of Novoron Bioscience. Shawn Gahr has over a decade of experience in financial analysis, business development, and project management with high-profile start-up companies, such as Apptio and Imperium Renewables. Shawn earned an M.P.I.A. in International Economics from UCSD, a B.S. in Business-Economics from Willamette University and holds a Certificate in Biomedical Regulatory Affairs from the University of Washington.
Follow Shawn Gahr:
About Novoron Bioscience: Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Stefan Hendriks
Chief Financial Officer & Internal Legal Counsel of Immunexpress
35 years experience – finance, legal, investment banking and investment, corporate advisory and business/industry development (HWC (SA), Deloittes, Hill Samuel, Macquarie Bank, AGL Ltd, NEVI Group (Nor), Management Board Huon Aquaculture Ltd (AU) for 18 years). Financed, developed IKEA in Queensland, Australia. Senior management and Board roles in South Africa, Australia, Scandinavia and the Netherlands.
Follow Stefan Hendriks:
About Immunexpress: Immunexpress Pty Ltd, a molecular diagnostics company, develops clinical assays for the management of immune disorders.
Thomas Waiss
Chief Financial Officer of Precision Image Analysis
Tom Waiss is experienced in finance and accounting with over 30 years in the computer/software industry. He has developed and supported service strategies at Hewlett Packard, Compaq and Digital Equipment Corporation. Tom has experience building new business lines and consulting practices within these companies.
Follow Thomas Waiss:
About Precision Image Analysis, Precision Image Analysis: Precision Image Analysis provides an innovative remote image post-processing analysis service for use in diagnostic medical studies.
Edward McClenny
CFO of Verasonics
Follow Edward McClenny:
About Verasonics: Verasonics is revolutionizing ultrasound with the development of leading-edge ultrasound research technologies.
Kendall Stever
Chief Financial Officer of Cerevast Therapeutics
Kendall joined Zonar in 2011 and serves as the Company’s Chief Financial Officer. Kendall brings 25 years of financial experience and leadership to Zonar, with a background working with high growth companies. Previously, Kendall was CFO of Verathon Medical, Inc., a leading designer, developer and manufacturer of proprietary medical devices. Verathon marketed its products globally with operations in 7 countries and was acquired by Roper Industries in 2009. Kendall was also Corporate Controller for Immunex Corporation, a premier developer of biopharmaceutical technology. He joined Immunex in 1990 and held various financial management positions during the company’s growth from a 200 person research company to a fully integrated research, manufacturing, and sales organization employing more than 2,000 employees with annual sales exceeding $1 billion. Kendall’s background also includes working with publicly and privately-held companies, as both an executive and consultant, in the areas of corporate compliance, projections and valuations, corporate financing, and accounting operations. He started his career in 1987 as an auditor with the public accounting firm of Deloitte and Touche. He is a CPA and holds a B.A. in business administration from the University of Washington.
Follow Kendall Stever:
About Cerevast Therapeutics, Zonar Systems: Cerevast Therapeutics is a medical technology company developing treatments for acute ischemic stroke and other vascular disorders.
Gary Onn
CFO of QuatRx Pharmaceuticals
Follow Gary Onn:
About QuatRx Pharmaceuticals: QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds
Gary Onn
CFO of QuatRx Pharmaceuticals
Follow Gary Onn:
About QuatRx Pharmaceuticals: QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds
Jordan Corey
Chief Financial Officer of Cero Therapeutics
Jordan Corey is the Chief Financial Officer at CERo Therapeutics.
Follow Jordan Corey:
About Cero Therapeutics: CERo Therapeutics, Inc. is a new cellular immunotherapy company.